ANTX icon

AN2 Therapeutics
ANTX

Overview Fund Activity

31 hedge funds and large institutions have $14.5M invested in AN2 Therapeutics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 22 closing their positions.

Holders
31
Holders Change
-14
Holders Change %
-31.11%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
8
Increased
8
Reduced
7
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
1
BML Capital Management
Indiana
$6.15M
2
AI
2
Acuitas Investments
Washington
$477K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$453K
4
AC
4
Aldebaran Capital
Indiana
$108K
5
BCM
5
Bridgeway Capital Management
Texas
$211K

Top Sellers

1
OCA
1
Octagon Capital Advisors
New York
$0
2
FLSM
2
Frazier Life Sciences Management
California
$0
3
RCM
3
RA Capital Management
Massachusetts
$2.14M
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
51
Qube Research & Technologies (QRT)
United Kingdom
– – -10,186 Closed
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
– – -2,812 Closed
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
– – -250 Closed
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3